Joshua T Kantrowitz

Summary

Affiliation: Nathan Kline Institute
Country: USA

Publications

  1. doi request reprint Schizoaffective disorder: a review of current research themes and pharmacological management
    Joshua T Kantrowitz
    Schizophrenia Research Center, Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
    CNS Drugs 25:317-31. 2011
  2. pmc Paliperidone: the evidence of its therapeutic value in schizophrenia
    Joshua Kantrowitz
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York, USA
    Core Evid 2:261-71. 2008
  3. pmc Reduction in tonal discriminations predicts receptive emotion processing deficits in schizophrenia and schizoaffective disorder
    Joshua T Kantrowitz
    Schizophrenia Research Center, Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA
    Schizophr Bull 39:86-93. 2013
  4. doi request reprint Glutamatergic transmission in schizophrenia: from basic research to clinical practice
    Joshua Kantrowitz
    Schizophrenia Research Institute, Nathan Kline Institute for Psychiatric Research, New York, USA
    Curr Opin Psychiatry 25:96-102. 2012
  5. doi request reprint Lurasidone for schizophrenia: what's different?
    Joshua T Kantrowitz
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY, USA
    Expert Rev Neurother 12:265-73. 2012
  6. pmc Seeing the world dimly: the impact of early visual deficits on visual experience in schizophrenia
    Joshua T Kantrowitz
    Department of Life Sciences, Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY, USA
    Schizophr Bull 35:1085-94. 2009
  7. doi request reprint A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia
    Joshua T Kantrowitz
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
    Clin Ther 31:1360-73. 2009
  8. pmc Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians
    Joshua T Kantrowitz
    Schizophrenia Research Center, Nathan S Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA
    Psychiatr Q 80:213-8. 2009
  9. pmc It's all in the cards: effect of stimulus manipulation on Wisconsin Card Sorting Test performance in schizophrenia
    Joshua T Kantrowitz
    Department of Life Sciences, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Psychiatry Res 168:198-204. 2009
  10. ncbi request reprint Risk of psychosis exacerbation by tricyclic antidepressants in unipolar Major Depressive Disorder with psychotic features
    Joshua T Kantrowitz
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    J Affect Disord 106:279-84. 2008

Detail Information

Publications17

  1. doi request reprint Schizoaffective disorder: a review of current research themes and pharmacological management
    Joshua T Kantrowitz
    Schizophrenia Research Center, Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
    CNS Drugs 25:317-31. 2011
    ..Additional clinical trials that include other antipsychotics, mood stabilizers and antidepressants are desirable and necessary before clear and comprehensive evidence-based treatment recommendations can be made...
  2. pmc Paliperidone: the evidence of its therapeutic value in schizophrenia
    Joshua Kantrowitz
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York, USA
    Core Evid 2:261-71. 2008
    ..It will become even harder to justify when risperidone becomes available as a less expensive generic medication...
  3. pmc Reduction in tonal discriminations predicts receptive emotion processing deficits in schizophrenia and schizoaffective disorder
    Joshua T Kantrowitz
    Schizophrenia Research Center, Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA
    Schizophr Bull 39:86-93. 2013
    ..Schizophrenia patients show decreased ability to identify emotion based upon tone of voice (voice emotion recognition), along with deficits in basic auditory processing. Interrelationship among these measures is poorly understood...
  4. doi request reprint Glutamatergic transmission in schizophrenia: from basic research to clinical practice
    Joshua Kantrowitz
    Schizophrenia Research Institute, Nathan Kline Institute for Psychiatric Research, New York, USA
    Curr Opin Psychiatry 25:96-102. 2012
    ..The past 20 years have seen the glutamatergic hypothesis go from theory to phase III trials of novel mechanism antipsychotics...
  5. doi request reprint Lurasidone for schizophrenia: what's different?
    Joshua T Kantrowitz
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY, USA
    Expert Rev Neurother 12:265-73. 2012
    ..It is recommended that lurasidone be administered once daily with at least 350 calories of food. Additional studies are desirable to directly compare and contrast lurasidone with other antipsychotic agents...
  6. pmc Seeing the world dimly: the impact of early visual deficits on visual experience in schizophrenia
    Joshua T Kantrowitz
    Department of Life Sciences, Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY, USA
    Schizophr Bull 35:1085-94. 2009
    ..01). This study replicates and expands upon previous findings with visual illusions. Our results offer a unifying explanation for disparate studies and suggest that deficits in early sensory gain affect subsequent integrative processes...
  7. doi request reprint A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia
    Joshua T Kantrowitz
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
    Clin Ther 31:1360-73. 2009
    ..A tolerability concern regarding use of GHB is its abuse potential. Given the high comorbidity of substance disorders and schizophrenia, a systematic assessment of the published literature is crucial...
  8. pmc Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians
    Joshua T Kantrowitz
    Schizophrenia Research Center, Nathan S Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA
    Psychiatr Q 80:213-8. 2009
    ..The two subject groups did not differ with respect to the prevalence of adolescent cannabis abuse or presence of affective symptoms. Further study is needed, with non-psychotic controls and larger samples...
  9. pmc It's all in the cards: effect of stimulus manipulation on Wisconsin Card Sorting Test performance in schizophrenia
    Joshua T Kantrowitz
    Department of Life Sciences, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Psychiatry Res 168:198-204. 2009
    ..Furthermore, progressive improvement was seen following repeated RFST administration. These findings demonstrate that stimulus characteristics, as well as executive deficits, contribute to impaired WCST performance in schizophrenia...
  10. ncbi request reprint Risk of psychosis exacerbation by tricyclic antidepressants in unipolar Major Depressive Disorder with psychotic features
    Joshua T Kantrowitz
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    J Affect Disord 106:279-84. 2008
    ..We conducted a systematic review of the published trials in unipolar Major Depressive Disorder with psychotic features (MDDP) to examine the risk of psychosis exacerbation by antidepressants...
  11. pmc Auditory emotion recognition impairments in schizophrenia: relationship to acoustic features and cognition
    Rinat Gold
    Center for Translational Schizophrenia Research, Orangeburg, NY, USA
    Am J Psychiatry 169:424-32. 2012
    ..The authors evaluated performance in schizophrenia on a novel voice emotion recognition battery with well-characterized physical features, relative to impairments in more general emotional and cognitive functioning...
  12. pmc High dose D-serine in the treatment of schizophrenia
    Joshua T Kantrowitz
    Schizophrenia Research Center, Nathan Kline Institute for Psychiatric Research New York University Langone School of Medicine, Orangeburg, NY, United States
    Schizophr Res 121:125-30. 2010
    ..We describe the first evaluation of the efficacy and safety of d-serine at doses >30 mg/kg/day; a 4-week, open-label trial of adjunctive D-serine (30, 60 or 120 mg/kg/day)...
  13. doi request reprint Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models
    Joshua T Kantrowitz
    Schizophrenia Research Center, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Clin Schizophr Relat Psychoses 4:189-200. 2010
    ..Glutamatergic theories, thus, open new potential approaches for treatment of schizophrenia, most of which are only now entering clinical evaluation...
  14. pmc N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?
    Joshua T Kantrowitz
    Schizophrenia Research Center, Nathan Kline Institute for Psychiatric Research New York University School of Medicine, 140 Old Orangeburg Road, Orangeburg, NY 10962, United States
    Brain Res Bull 83:108-21. 2010
    ....
  15. ncbi request reprint Olanzapine: review of safety 2008
    Joshua T Kantrowitz
    Fellow, Nathan S Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA
    Expert Opin Drug Saf 7:761-9. 2008
    ..Olanzapine is a second-generation antipsychotic approved for the treatment of schizophrenia, bipolar mania and associated agitation...
  16. doi request reprint Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction?
    Leslie Citrome
    Nathan S Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA
    Expert Rev Neurother 9:1045-58. 2009
    ..This is somewhat supported by double-blind, controlled clinical trial evidence, but only for selected patients with severe and/or persistent symptoms...
  17. doi request reprint Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings
    Eline M P Poels
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA New York State Psychiatric Institute, New York, NY, USA
    Schizophr Res 152:325-32. 2014
    ..We will review the contribution of (1)H-MRS studies to our knowledge about glutamatergic abnormalities in the brains of individuals with SCZ and discuss the implications for future research and clinical care. ..